Evidence map›Paper›PMID 40892915›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Lysosomal reduced thiols are essential for mouse embryonic development.

Charles H Adelmann, Avanthika Venkatachalam, Lingjuan Huang, Michelle Liu, Sharon Germana, Stefan A Harry, Paul C Rosen, Joshua Herron, Pei-Chieh Tien, Liron Bar-Peled and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Lysosome as a Chemical Reactor.International journal of molecular sciences · 2025
    Review
  2. Lysosomal reduced thiols are essential for mouse embryonic development.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Charles H AdelmannCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.
Avanthika VenkatachalamCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0001-9429-0659
Lingjuan HuangCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.
Michelle LiuCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.
Sharon GermanaCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.
Stefan A HarryKrantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA 02114.
Paul C RosenDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-7414-454X
Joshua HerronCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.
Pei-Chieh TienKrantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA 02114.
Liron Bar-PeledKrantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA 02114.
David M SabatiniInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague 166 10, Czech Republic.ORCID 0000-0002-1446-7256
David E FisherCutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114.

Funding

Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 2013 to 2026
$25.3M
The MITF transcriptional network: melanoma risk and carcinogenesisR01AR043369 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 1996 to 2026
$9.4M
Therapeutic strategies for treatment of giant congenital melanocytic neviR01AR072304 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 2017 to 2026
$3.9M
Deciphering the Role of Reductive Stress in Non Small Cell Lung CancerR37CA260062 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Liron Bar-Peled · 2022 to 2026
$1.9M
American Cancer Society (ACS) PF-23-1018904-01-ETDamon Runyon Cancer Research Foundation (DRCRF) DG-2454-22Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) NALancer Professorship at Harvard Medical School NALEO Fondet (LEO Foundation) LF18057Melanoma Research Alliance (MRA) NANCI NIH HHS P01 CA163222NCI NIH HHS R37 CA260062NIAMS NIH HHS R01 AR043369NIAMS NIH HHS R01 AR072304Water Cove Charitable Foundation NA
6 · The paper itself

Abstract

While it has been appreciated for decades that lysosomes can import cysteine, its significance for whole-organism physiology has remained uncertain. Recent work identified MFSD12 as a transmembrane protein required for cysteine import into lysosomes (and melanosomes), enabling genetic interrogation of this pathway. Here, we show that

Indexed as

Embryonic DevelopmentLysosomesSulfhydryl CompoundsAmino Acid Transport Systems, NeutralAnimalsCysteamineCysteineCystineFemaleMiceMice, KnockoutOxidation-ReductionAmino Acid Transport Systems, NeutralCysteamineCysteineCystineSulfhydryl CompoundscysteinelysosomeMFSD12redox

Identifiers

PMID40892915
PMCPMC12435214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.